96 related articles for article (PubMed ID: 28555543)
21. Allosteric Regulation of Phosphatidylinositol 4-Kinase III Beta by an Antipicornavirus Compound MDL-860.
Arita M; Dobrikov G; Pürstinger G; Galabov AS
ACS Infect Dis; 2017 Aug; 3(8):585-594. PubMed ID: 28605587
[TBL] [Abstract][Full Text] [Related]
22. Enterovirus inhibitory activity of C-8-tert-butyl substituted 4-aryl-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-ones.
Kumar Biswas B; Malpani YR; Ha N; Kwon DH; Soo Shin J; Kim HS; Kim C; Bong Han S; Lee CK; Jung YS
Bioorg Med Chem Lett; 2017 Aug; 27(15):3582-3585. PubMed ID: 28587824
[TBL] [Abstract][Full Text] [Related]
23. Metagenomic Analysis Identified Human Rhinovirus B91 Infection in an Adult Suffering from Severe Pneumonia.
Yan F; Xiao Y; Li M; Zhang H; Zhang R; Zhou H; Shen H; Wang J; Li W; Ren L
Am J Respir Crit Care Med; 2017 Jun; 195(11):1535-1536. PubMed ID: 28569582
[No Abstract] [Full Text] [Related]
24. Mitochondrial protein p32/HAPB1/gC1qR/C1qbp is required for efficient respiratory syncytial virus production.
Hu M; Li HM; Bogoyevitch MA; Jans DA
Biochem Biophys Res Commun; 2017 Aug; 489(4):460-465. PubMed ID: 28576489
[TBL] [Abstract][Full Text] [Related]
25. Respiratory syncytial virus: prospects for new and emerging therapeutics.
Jorquera PA; Tripp RA
Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729
[TBL] [Abstract][Full Text] [Related]
26.
Czakó R; Vogel L; Lamirande EW; Bock KW; Moore IN; Ellebedy AH; Ahmed R; Mehle A; Subbarao K
mBio; 2017 May; 8(3):. PubMed ID: 28559489
[TBL] [Abstract][Full Text] [Related]
27. Role of human rhinovirus in triggering human airway epithelial-mesenchymal transition.
Minor DM; Proud D
Respir Res; 2017 May; 18(1):110. PubMed ID: 28558698
[TBL] [Abstract][Full Text] [Related]
28. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
Ko JH; Müller MA; Seok H; Park GE; Lee JY; Cho SY; Ha YE; Baek JY; Kim SH; Kang JM; Kim YJ; Jo IJ; Chung CR; Hahn MJ; Drosten C; Kang CI; Chung DR; Song JH; Kang ES; Peck KR
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2179-2186. PubMed ID: 28695355
[TBL] [Abstract][Full Text] [Related]
29. Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay.
Aouadi W; Eydoux C; Coutard B; Martin B; Debart F; Vasseur JJ; Contreras JM; Morice C; Quérat G; Jung ML; Canard B; Guillemot JC; Decroly E
Antiviral Res; 2017 Aug; 144():330-339. PubMed ID: 28676301
[TBL] [Abstract][Full Text] [Related]
30. Does atopy affect the course of viral pneumonia?
Erdem SB; Can D; Girit S; Çatal F; Şen V; Pekcan S; Yüksel H; Bingöl A; Bostancı I; Erge D; Ersu R
Allergol Immunopathol (Madr); 2018; 46(2):119-126. PubMed ID: 28634031
[TBL] [Abstract][Full Text] [Related]
31. Human picornaviruses associated with neurological diseases and their neutralization by antibodies.
Anastasina M; Domanska A; Palm K; Butcher S
J Gen Virol; 2017 Jun; 98(6):1145-1158. PubMed ID: 28631594
[TBL] [Abstract][Full Text] [Related]
32. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
33. Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase.
Yang Y; Gao Y; Zhang L; Liu X; Sun Y; Bai J; Jiang P
Vet Res; 2023 Dec; 54(1):124. PubMed ID: 38124181
[TBL] [Abstract][Full Text] [Related]
34. Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances.
Tammaro C; Guida M; Appetecchia F; Biava M; Consalvi S; Poce G
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259352
[TBL] [Abstract][Full Text] [Related]
35. Unlocking STING as a Therapeutic Antiviral Strategy.
Paulis A; Tramontano E
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108610
[TBL] [Abstract][Full Text] [Related]
36. A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor.
Morton TL; Laskin OL; Kaushik D; Lee L; Ma J; Kristensen A; O'Keefe K; Golden L; Klein M; Kong R
Pharmacol Res Perspect; 2023 Apr; 11(2):e01076. PubMed ID: 36938928
[TBL] [Abstract][Full Text] [Related]
37. Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the
Sharma K; Berry L; Vryonis E; Ali A; Lara B; Noufaily A; Parsons N; Bradley C; Haley B; Tabuso M; Arasaradnam RP
BMJ Open; 2022 Nov; 12(11):e055205. PubMed ID: 36396307
[TBL] [Abstract][Full Text] [Related]
38. The Novel
Sibille G; Luganini A; Sainas S; Boschi D; Lolli ML; Gribaudo G
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298835
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy.
Sepúlveda CS; García CC; Damonte EB
Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014049
[TBL] [Abstract][Full Text] [Related]
40. Virtual screening of Indonesian herbal compounds as COVID-19 supportive therapy: machine learning and pharmacophore modeling approaches.
Erlina L; Paramita RI; Kusuma WA; Fadilah F; Tedjo A; Pratomo IP; Ramadhanti NS; Nasution AK; Surado FK; Fitriawan A; Istiadi KA; Yanuar A
BMC Complement Med Ther; 2022 Aug; 22(1):207. PubMed ID: 35922786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
